Asia Pacific in Vitro Diagnostics Market Demand, Growth And Development Trends By 2014 - 2024.
The regional IVD market is classified in to Japan, India, and China. China is projected to grow at the highest CAGR during the study period. The increasing per capita income and rising GDP are factors responsible for the growth of these markets.
Moreover, the developing economies such as that of India have attracted various companies to invest in these countries. The increasing population also has led to the increased demand of IVD in the Asia Pacific region. On the basis of the end use, the IVD market in the Asia Pacific region is classified into the hospitals, laboratories, homecare diagnostics, and others. Being the primary healthcare center, hospital held the largest revenue share in 2015.
Download Free Sample - https://www.millioninsights.com/industry-reports/asia-pacific-in-vitro-diagnostics-ivd-market/request-sample
Competitive market Share Insights
The major players include Affymetrix, Inc., Danaher Corporation, Alere, Inc, Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Vela Diagnostics, Inc., Siemens Healthcare Diagnostics, Inc., among others.
In order to gain a competitive edge in the market, major players have undertaken several organic as well as inorganic strategies. Some of the key strategies include new product launch and development, geographic expansion, mergers, acquisition, and agreement among others.
Comments
Post a Comment